Human stem cell models point to glia as key players in multiple sclerosis
Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens...
multiple sclerosis
Fixing rogue brain cells may hold key to preventing neurodegeneration
Harmful astrocytes or "rogue cells" in red.
Case Western Reserve University postdoctoral researcher to lead MS study with new career transition fellowship from National Multiple Sclerosis Society
Treatments for multiple sclerosis (MS) can control relapses, but don’t stop the disease from progressing—or promote brain repair....
Case Western Reserve University researcher secures $1.2M to develop MS diagnostic tests
Case Western Reserve University researcher Farren Briggs was awarded $1.2 million over three years from the National Institute of Neurological...
New drug that could aid earlier MS diagnoses approved by FDA for first human clinical trials
Created by Case Western Reserve University researchers, the drug will be tested in healthy volunteers at Cleveland Clinic...
Convelo Therapeutics, founded on discoveries at Case Western Reserve, to develop regenerative medicines for neurological disorders
Convelo Therapeutics Inc., a company founded on seminal scientific discoveries made in the laboratories of Paul Tesar and...
A new roadmap for repairing the damage of multiple sclerosis
Dozens of drug candidates identified that share a common mechanism to stimulate regeneration of the brain’s myelinating cells...
Case Western Reserve University awarded $4.9 million to test digital methods of reducing MS-related fatigue
With geographic barriers limiting treatment options for many people with multiple sclerosis (MS), a Case Western Reserve University...